Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Recode Therapeutics

Clinical trials sponsored by Recode Therapeutics, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New inhaled drug for cystic fibrosis enters human testing Results expected Nov 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1 Completed 3

New inhaled drug for cystic fibrosis enters human testing

Disease control Ongoing

This study is the first time the drug RCT2100 is being tested in humans. It aims to check the safety and tolerability of single and multiple doses in healthy adults and people with cystic fibrosis (CF). The trial will also see how the drug spreads in the body and gather early pro…

Phase 2 • Sponsor: ReCode Therapeutics • Aim: Disease control

Last updated Aug 21, 2026 00:00 UTC